Author
Listed:
- Khaled Ali
(Ludwig Institute for Cancer Research
University College London)
- Antonio Bilancio
(Ludwig Institute for Cancer Research)
- Matthew Thomas
(Novartis Institutes for BioMedical Research)
- Wayne Pearce
(Ludwig Institute for Cancer Research)
- Alasdair M. Gilfillan
(National Institutes of Health)
- Christine Tkaczyk
(National Institutes of Health)
- Nicolas Kuehn
(Frimorfo)
- Alexander Gray
(University of Dundee)
- June Giddings
(Novartis Institutes for BioMedical Research)
- Emma Peskett
(Ludwig Institute for Cancer Research)
- Roy Fox
(Novartis Institutes for BioMedical Research)
- Ian Bruce
(Novartis Institutes for BioMedical Research)
- Christoph Walker
(Novartis Institutes for BioMedical Research)
- Carol Sawyer
(Ludwig Institute for Cancer Research
Institute of Cancer Research)
- Klaus Okkenhaug
(Ludwig Institute for Cancer Research
the Babraham Institute)
- Peter Finan
(Novartis Institutes for BioMedical Research)
- Bart Vanhaesebroeck
(Ludwig Institute for Cancer Research
University College London)
Abstract
Inflammatory substances released by mast cells induce and maintain the allergic response1,2. Mast cell differentiation and activation are regulated, respectively, by stem cell factor (SCF; also known as Kit ligand) and by allergen in complex with allergen-specific immunoglobulin E (IgE)2,3. Activated SCF receptors and high-affinity receptors for IgE (FcɛRI) engage phosphoinositide 3-kinases (PI(3)Ks) to generate intracellular lipid second messenger signals2,3,4,5. Here, we report that genetic or pharmacological inactivation of the p110δ isoform of PI(3)K in mast cells leads to defective SCF-mediated in vitro proliferation, adhesion and migration, and to impaired allergen–IgE-induced degranulation and cytokine release. Inactivation of p110δ protects mice against anaphylactic allergic responses. These results identify p110δ as a new target for therapeutic intervention in allergy and mast-cell-related pathologies.
Suggested Citation
Khaled Ali & Antonio Bilancio & Matthew Thomas & Wayne Pearce & Alasdair M. Gilfillan & Christine Tkaczyk & Nicolas Kuehn & Alexander Gray & June Giddings & Emma Peskett & Roy Fox & Ian Bruce & Christ, 2004.
"Essential role for the p110δ phosphoinositide 3-kinase in the allergic response,"
Nature, Nature, vol. 431(7011), pages 1007-1011, October.
Handle:
RePEc:nat:nature:v:431:y:2004:i:7011:d:10.1038_nature02991
DOI: 10.1038/nature02991
Download full text from publisher
As the access to this document is restricted, you may want to search for a different version of it.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:nature:v:431:y:2004:i:7011:d:10.1038_nature02991. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.